At the Academy of Nutrition and Dietetics Food and Nutrition Conference & Expo in October 2025, Rachelle Lacroix Mallik, founder and reproductive dietitian at The Food Therapist in Winnetka, Illinois, presented on GLP-1s and fertility and quickly dispelled any rumors of a magic fix
Karagiannis T, et al
For example, Ozempic is covered only to treat diabetes, and Wegovy is covered for the indication of Major Adverse Cardiovascular Events (MACE) reduction in overweight/obese adults, but neither are currently covered for obesity as a standalone condition
Cork says this association should be studied to determine whether these medications affect otherwise healthy individuals in the same way
The GLP-1 Market: A Booming Opportunity: GLP-1-based therapies have emerged as promising treatments for obesity and diabetes, offering significant weight loss benefits and improved glycemic control
The mechanism relates to slower drug clearance in women and potentially different receptor sensitivity patterns